Literature DB >> 15737896

Gastropathic sideropenia.

Chaim Hershko1, Amnon Lahad, Dan Kereth.   

Abstract

There has been an increasing awareness recently of subtle, non-bleeding gastrointestinal conditions that may result in abnormal iron absorption leading to iron-deficiency anaemia (IDA) in the absence of gastrointestinal symptoms. Thus, the importance of coeliac disease as a possible cause of IDA refractory to oral iron treatment, without other manifestations of malabsorption syndrome, is increasingly being recognized. In addition, Helicobacter pylori has been implicated in several recent studies as a cause of IDA refractory to oral iron treatment, and the anaemia responds favourably to H. pylori eradication. Likewise, achlorhydric gastric atrophy or atrophic body gastritis (ABG), a condition associated with chronic idiopathic iron deficiency, has been shown to be responsible for refractory IDA in over 20% of patients with no evidence of gastrointestinal blood loss. It has also been suggested that H. pylori gastritis may represent an early phase of ABG in which infection may trigger an autoimmune process directed against gastric parietal cells by means of antigenic mimicry. In this review we examine in a critical manner the role of H. pylori gastritis in the causation of IDA, the role of ABG in the pathogenesis of iron malabsorption, the evidence supporting a possible cause-and-effect relationship between H. pylori gastritis and ABG, and the implications of these findings for the diagnostic work-up and management of IDA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15737896     DOI: 10.1016/j.beha.2004.10.002

Source DB:  PubMed          Journal:  Best Pract Res Clin Haematol        ISSN: 1521-6926            Impact factor:   3.020


  9 in total

Review 1.  Extragastric diseases associated with Helicobacter pylori infection.

Authors:  Karen J Goodman; Stephanie L Joyce; Kathleen P Ismond
Journal:  Curr Gastroenterol Rep       Date:  2006-12

2.  Association between helicobacter pylori infection and serum iron profile.

Authors:  Durdi Qujeq; Maryam Sadogh; Shahreyar Savadkohi
Journal:  Caspian J Intern Med       Date:  2011

Review 3.  Clinical practice: diagnosis and evaluation of dyspepsia.

Authors:  David Yates Graham; Massimo Rugge
Journal:  J Clin Gastroenterol       Date:  2010-03       Impact factor: 3.062

Review 4.  Eradication of gastric cancer and more efficient gastric cancer surveillance in Japan: two peas in a pod.

Authors:  David Y Graham; Masahiro Asaka
Journal:  J Gastroenterol       Date:  2009-08-28       Impact factor: 7.527

Review 5.  African, Asian or Indian enigma, the East Asian Helicobacter pylori: facts or medical myths.

Authors:  David Y Graham; Hong Lu; Yoshio Yamaoka
Journal:  J Dig Dis       Date:  2009-05       Impact factor: 2.325

6.  Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond.

Authors:  David Y Graham; Hong Lu; Yoshio Yamaoka
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 7.  Efficient identification and evaluation of effective Helicobacter pylori therapies.

Authors:  David Y Graham
Journal:  Clin Gastroenterol Hepatol       Date:  2008-10-30       Impact factor: 11.382

8.  Lactoferrin levels in the gastric tissue of Helicobacter pylori-positive and -negative patients and its effect on anemia.

Authors:  Yaşar Doğan; Tülay Erkan; Zerrin Önal; Merve Usta; Gülen Doğusoy; Fügen Çullu Çokuğraş; Tufan Kutlu
Journal:  Mediators Inflamm       Date:  2012-03-19       Impact factor: 4.711

9.  Serum prohepcidin levels are lower in patients with atrophic gastritis.

Authors:  Hyung-Keun Kim; Eun-Chul Jang; Ju-Ok Yeom; Sun-Young Kim; Hyunjung Cho; Sung Soo Kim; Hiun-Suk Chae; Young-Seok Cho
Journal:  Gastroenterol Res Pract       Date:  2013-02-28       Impact factor: 2.260

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.